E-LIB Suche - Ergebnisse für: Wu, Yilong

1

ToolEyes: Fine-Grained Evaluation for Tool Learning Capabil..:

Ye, Junjie ; Li, Guanyu ; Gao, Songyang...
http://arxiv.org/abs/2401.00741. , 2024

Link: http://arxiv.org/abs/240..

2

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treat..:

Cho, Byoung Chul ; Lee, Jong Seok ; Wu, Yi-Long...
Journal of Thoracic Oncology, 18 (12) , p. 1731 -1742. , 2024

Link: http://hdl.handle.net/19..

3

RoTBench: A Multi-Level Benchmark for Evaluating the Robust..:

Ye, Junjie ; Wu, Yilong ; Gao, Songyang...
http://arxiv.org/abs/2401.08326. , 2024

Link: http://arxiv.org/abs/240..

4

Efficacy and safety of first-line lorlatinib versus crizoti..:

Solomon, Benjamin J ; Bauer, Todd M ; Mok, Tony S K...
The Lancet Respiratory Medicine, Vol.11 No.4, pp.354-366. , 2023

Link: https://hdl.handle.net/1..

5

Asian Thoracic Oncology Research Group (ATORG) Expert Conse..:

Ahn, Myung-Ju ; Mendoza, Marvin Jonne L ; Pavlakis, Nick...
Clinical Lung Cancer, Vol.23 No.8, pp.670-685. , 2023

Link: https://hdl.handle.net/1..

6

Final Overall Survival, Safety, and Quality of Life Results..:

Wu, Yi-Long ; Lu, Shun ; Yang, James Chih-Hsin...
JTO Clinical and Research Reports, Vol.3 No.10, p. 100406. , 2023

Link: https://hdl.handle.net/1..

7

Lazertinib Versus Gefitinib as First-Line Treatment in Pati..:

Cho, Byoung Chul ; Ahn, Myung-Ju ; Kang, Jin Hyoung...
Journal of Clinical Oncology, Vol.41 No.26, pp.4208-+. , 2023

Link: https://hdl.handle.net/1..

8

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A ; Chang, Gee-Chen...
JTO Clinical and Research Reports, Vol.4 No.5, p. 100499. , 2023

Link: https://hdl.handle.net/1..

9

Genome-wide association study of lung adenocarcinoma in Eas..:

Shi, Jianxin ; Shiraishi, Kouya ; Choi, Jiyeon...
2041-1723. , 2023

Link: https://dspace.library.u..

10

Brief Report: Durvalumab After Chemoradiotherapy in Unresec..:

Naidoo, Jarushka ; Antonia, Scott ; Wu, Yi-Long...
Naidoo , J , Antonia , S , Wu , Y-L , Cho , B C , Thiyagarajah , P , Mann , H , Newton , M & Faivre-Finn , C 2023 , ' Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-mutant NSCLC: A Post-Hoc Subgroup Analysis from PACIFIC ' , Journal of Thoracic Oncology , vol. 18 , no. 5 , pp. 657-663 . https://doi.org/10.1016/j.jtho.2023.02.009. , 2023

Link: https://research.manches..

11